Health
New targeted therapy blocks metabolism in brain cancer cells with genetic vulnerability – Medical Xpress
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways…
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways in cancer cells with specific genetic defects. Preclinical studies found the small-molecule enolase inhibitor to be effective in killing brain cancer cells that were missing ENO1, one of two genes encoding the enolase enzyme.
The study results, published today in Nature Metabolism, provide proof of principle for a treatment strategy known…
-
General18 hours agoDavid Littleproud’s own goal • Inside Story
-
Noosa News18 hours agoQueensland GP accused of rape, sexual assault and torture pleads for bail despite ‘disturbing’ allegations
-
General10 hours agoCoalition to chart path forward as family feud cooled
-
General7 hours agoStar Wars’ fascist dystopia has never felt closer than in new season of Andor